NJ A 1510
introducedImproves access to lower cost generic and biosimilar drugs and revises certain requirements regarding dispensing of biosimilar drugs by pharmacies.*
New Jersey · 222 · lower
Quick answers
Did NJ A 1510 pass?
Not yet. NJ A 1510 has been introduced as of 2026-06-04 but has not advanced to a vote. Latest recorded action (2026-06-04): Reported out of Assembly Comm. with Amendments, 2nd Reading
What is NJ A 1510 about?
NJ A 1510 is a bill in the 222 titled “Improves access to lower cost generic and biosimilar drugs and revises certain requirements regarding dispensing of biosimilar drugs by pharmacies.*”.
Who sponsors NJ A 1510?
Freiman, Roy, Stanley, Sterley S. are the primary sponsors of NJ A 1510.
- Introduced
- 2026-01-13
- Latest action
- 2026-06-04 — Reported out of Assembly Comm. with Amendments, 2nd Reading
- Bill type
- bill
- Last updated
- —
Sponsors
- Freiman, Royprimary
- Stanley, Sterley S.primary
Committees
Not provided by source.
Action timeline
2026-01-13
Introduced, Referred to Assembly Financial Institutions and Insurance Committee
introduction,referral-committee
2026-06-04
Reported out of Assembly Comm. with Amendments, 2nd Reading
reading-2
Versions
Documents
Votes
Not provided by source.
Related bills
- Companion bill: S 4222
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:27:43.923511Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NJ&identifier=A 1510. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.